Greenwich Wealth Management’s Aspira Women's Health Inc. Common Stock AWH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-21,391
Closed -$117K 248
2023
Q1
$117K Sell
21,391
-11,564
-35% -$78.5K 0.01% 219
2022
Q4
$164K Buy
32,955
+1,155
+4% +$6.31K 0.02% 219
2022
Q3
$178K Buy
31,800
+1,156
+4% +$12.4K 0.02% 216
2022
Q2
$270K Buy
30,644
+2,431
+9% +$24.7K 0.04% 201
2022
Q1
$440K Hold
28,213
0.04% 170
2021
Q4
$749K Buy
28,213
+174
+0.6% +$6.6K 0.06% 131
2021
Q3
$1.37M Buy
28,039
+167
+0.6% +$10.3K 0.11% 92
2021
Q2
$2.35M Buy
27,872
+21,293
+324% +$1.83M 0.2% 62
2021
Q1
$666K Sell
6,579
-17
-0.3% -$1.87K 0.05% 127
2020
Q4
$664K Buy
6,596
+33
+0.5% +$2.2K 0.06% 115
2020
Q3
$304K Buy
6,563
+1,417
+28% +$72.7K 0.05% 147
2020
Q2
$296K Buy
+5,146
New +$344K 0.06% 142

Other funds holding AWH

Greenwich Wealth Management's AWH Position: Q2 2023 in Review

Greenwich Wealth Management sold out of Aspira Women's Health Inc. Common Stock (AWH) in Q2 2023, closing a stake of 21,391 shares — an estimated $117K sold.

Greenwich Wealth Management first reported a position in AWH in Q2 2020 and held it in 12 quarters. The position peaked at $2.35M in Q2 2021. 22 funds tracked by Wall St. Rank hold AWH as of Q2 2023.

  • Greenwich Wealth Management reported no remaining Aspira Women's Health Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Greenwich Wealth Management sold 21,391 Aspira Women's Health Inc. Common Stock shares in Q2 2023, an estimated $117K.
  • Greenwich Wealth Management first reported a position in Aspira Women's Health Inc. Common Stock in Q2 2020 and held it in 12 quarters.
  • Greenwich Wealth Management's Aspira Women's Health Inc. Common Stock position peaked at $2.35M in Q2 2021.
  • 22 funds tracked by Wall St. Rank held Aspira Women's Health Inc. Common Stock as of Q2 2023.

Based on Greenwich Wealth Management's 13F filing for Q2 2023, filed 31 Jul 2023.